Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,360.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 1,719.00
  • 52 Week Low: 1,149.00
  • Currency: UK Pounds
  • Shares Issued: 226.75m
  • Volume: 674,490
  • Market Cap: £3,083.77m
  • RiskGrade: 134

Abcam Overview

Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in understanding health and disease.

Key Personnel

CEO: Alan Thomas Hirzel
CFO: Michael Baldock
Non-Executive Chairman: Peter Allen
Senior Independent Director: Giles Kerr
Non-Executive Dir: Mara G Aspinall, Bessie Lee, Mark Capone

Contact Details

Address: Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom , CB2 0AX
Phone: +44 (0)1223 696 000
Fax: +44 (0)1223 215 215
Website: http://www.abcam.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-ShareFTSE AIM 50FTSE AIM 100
ISIN: GB00B6774699

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Abcam Market Data

Currency UK Pounds
Share Price 1,360.00p
Change Today -8.00p
% Change -0.58 %
52 Week High 1,719.00
52 Week Low 1,149.00
Volume 674,490
Shares Issued 226.75m
Market Cap £3,083.77m
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.37% below the market average97.37% below the market average97.37% below the market average97.37% below the market average97.37% below the market average
92.31% below the sector average92.31% below the sector average92.31% below the sector average92.31% below the sector average92.31% below the sector average
Price Trend
70.04% below the market average70.04% below the market average70.04% below the market average70.04% below the market average70.04% below the market average
66.1% below the sector average66.1% below the sector average66.1% below the sector average66.1% below the sector average66.1% below the sector average
Income
98.85% below the market average98.85% below the market average98.85% below the market average98.85% below the market average98.85% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Growth
74.36% below the market average74.36% below the market average74.36% below the market average74.36% below the market average74.36% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 7
Sell 0
Strong Sell 1
Total 10
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 18-Jun-2021

Time Volume / Share Price
16:51 22,825 @ 1,361.66p
16:35 157,738 @ 1,360.00p
16:29 88 @ 1,357.00p
16:29 39 @ 1,357.00p
16:29 142 @ 1,358.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page